669-677 Molecular characterization of CD133+ cancer stem-like cells in endometrial cancer

International Journal of Oncology

Volumn 44, Issue 3, 2014, Pages 669-677

  Nakamura, Mitsuhiro ^a   Zhang, Xiuzhi ^a   Mizumoto, Yasunari ^a   Maida, Yoshiko ^a   Bono, Yukiko ^a   Takakura, Masahiro ^a   Kyo, Satoru ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Cancer stem cell; CD133; Endometrial cancer; MT1 MMP; Side population

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CD133 ANTIGEN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; SMALL INTERFERING RNA; ABC TRANSPORTER; ABCG2 PROTEIN, HUMAN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE; TUMOR PROTEIN;

ARTICLE; CANCER RESISTANCE; CANCER STEM CELL; CARCINOGENESIS; CELL INVASION; CELL POPULATION; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; UPREGULATION; BIOSYNTHESIS; ENDOMETRIUM TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROARRAY ANALYSIS; PATHOLOGY; TUMOR CELL LINE;

ANTIGENS, CD; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE, TUMOR; ENDOMETRIAL NEOPLASMS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HUMANS; MATRIX METALLOPROTEINASE 14; MICROARRAY ANALYSIS; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; PEPTIDES; RNA, SMALL INTERFERING;

EID: 84896712855     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.2230     Document Type: Article

References (34)

1. Matsuda T, Marugame T, Kamo K, et al: Cancer incidence and incidence rates in Japan in 2006: Based on data from 15 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol 42: 139-147, 2012.
2. Kyo S: Endometrial cancer stem cells: Are they a possible therapeutic target? Curr Obstet Gynecol Rep 2: 1-10, 2013.
3. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988, 2003. (Pubitemid 36418143)
4. Singh SK, Hawkins C, Clarke ID, et al: Identification of human brain tumour-initiating cells. Nature 432: 396-401, 2004. (Pubitemid 39551674)
5. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q and Hjelmeland AB: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760, 2006. (Pubitemid 44949604)
6. Gu G, Yuan J, Wills M and Kasper S: Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res 67: 4807-4815, 2007. (Pubitemid 46910189)
7. Miki J, Furusato B, Li H, et al: Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res 67: 3153-3161, 2007. (Pubitemid 46724852)
8. Eramo A, Lotti F, Sette G, et al: Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15: 504-514, 2008. (Pubitemid 351267301)
9. Hermann PC, Huber SL, Herrler T, et al: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1: 313-323, 2007. (Pubitemid 47355323)
10. O'Brien CA, Pollett A, Gallinger S and Dick JE: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106-110, 2007. (Pubitemid 46067310)
11. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M and Peschle C: Identification and expansion of human colon cancer - initiating cells. Nature 445: 111-115, 2007. (Pubitemid 46067311)
12. Monzani E, Facchetti F, Galmozzi E, et al: Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer 43: 935-946, 2007. (Pubitemid 46366698)
13. Rutella S, Bonanno G, Procoli A, et al: Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors. Clin Cancer Res 15: 4299-4311, 2009.
14. Nakamura M, Kyo S, Zhang B, et al: Prognostic impact of CD133 expression as a tumor-initiating cell marker in endometrial cancer. Hum Pathol 41: 1516-1529, 2010.
15. Nakamura M, Bodily JM, Beglin M, Kyo S, Inoue M and Laimins LA: Hypoxia-specific stabilization of HIF-1alpha by human papillomaviruses. Virology 387: 442-448, 2009.
16. Mizumoto Y, Kyo S, Mori N, et al: Activation of ERK1/2 occurs independently of KRAS or BRAF status in endometrial cancer and is associated with favorable prognosis. Cancer Sci 98: 652-658, 2007. (Pubitemid 46563440)
17. Mizumoto Y, Kyo S, Ohno S, et al: Creation of tumorigenic human endometrial epithelial cells with intact chromosomes by introducing defined genetic elements. Oncogene 25: 5673-5682, 2006. (Pubitemid 44387623)
18. Kato K, Takao T, Kuboyama A, et al: Endometrial cancer side-population cells show prominent migration and have a potential to differentiate into the mesenchymal cell lineage. Am J Pathol 176: 381-392, 2010.
19. Visvader JE and Lindeman GJ: Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8: 755-768, 2008.
20. Maeda S, Shinchi H, Kurahara H, et al: CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer. Br J Cancer 98: 1389-1397, 2008. (Pubitemid 351543575)
21. Kojima M, Ishii G, Atsumi N, Fujii S, Saito N and Ochiai A: Immunohistochemical detection of CD133 expression in colorectal cancer: a clinicopathological study. Cancer Sci 99: 1578-1583, 2008.
22. + HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene 27: 1749-1758, 2008.
23. Kim M, Turnquist H, Jackson J, et al: The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clin Cancer Res 8: 22-28, 2002. (Pubitemid 34101455)
24. Doyle LA and Ross DD: Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 22: 7340-7358, 2003. (Pubitemid 37487163)
25. Chiba T, Kita K, Zheng YW, et al: Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 44: 240-251, 2006. (Pubitemid 44049156)
26. Ho MM, Ng AV, Lam S and Hung JY: Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 67: 4827-4833, 2007. (Pubitemid 46910191)
27. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, et al: Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci USA 103: 11154-11159, 2006. (Pubitemid 44156488)
28. Christgen M, Ballmaier M, Bruchhardt H, von Wasielewski R, Kreipe H and Lehmann U: Identification of a distinct side population of cancer cells in the Cal-51 human breast carcinoma cell line. Mol Cell Biochem 306: 201-212, 2007. (Pubitemid 350001832)
29. Wang YH, Li F, Luo B, et al: A side population of cells from a human pancreatic carcinoma cell line harbors cancer stem cell characteristics. Neoplasma 56: 371-378, 2009.
30. Annabi B, Rojas-Sutterlin S, Laflamme C, et al: Tumor environment dictates medulloblastoma cancer stem cell expression and invasive phenotype. Mol Cancer Res 6: 907-916, 2008.
31. Kohga K, Tatsumi T, Takehara T, et al: Expression of CD133 confers malignant potential by regulating metalloproteinases in human hepatocellular carcinoma. J Hepatol 52: 872-879, 2010.
32. Kabashima A, Higuchi H, Takaishi H, et al: Side population of pancreatic cancer cells predominates in TGF-beta-mediated epithelial to mesenchymal transition and invasion. Int J Cancer 124: 2771-2279, 2009.
33. Armstrong AJ, Marengo MS, Oltean S, et al: Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol Cancer Res 9: 997-1007, 2011.
34. Oda K, Arakawa H, Tanaka T, et al: p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 102: 849-862, 2000.